A Study to Assess the Effects of PT001 and PT005 MDI on Specific Image Based Parameters in Subjects with Moderate to Severe COPD

Trial Identifier:	PT003019
Sponsor:	Pearl Therapeutics, Inc.
NCTID::	NCT02937584
Start Date:	December 2016
Primary Completion Date:	May 2018

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	Dutch Translation
	French Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Belgium	Edegem, Belgium, 2650
Belgium	Erpent, Belgium, 5101

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.